Posted inCardiology news Specialties
Risks and Realities of Withdrawing Heart Failure Medications After Ejection Fraction Improvement
Withdrawal of renin-angiotensin inhibitors and mineralocorticoid receptor antagonists in patients with heart failure and improved ejection fraction significantly increases 1-year cardiovascular mortality and hospitalization risks; beta-blocker withdrawal shows varied effects based on EF.